Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s State FDA Sees Big Challenges In Food And Drug Administration

This article was originally published in PharmAsia News

Executive Summary

After last year's governmental reform, China's State FDA is now responsible for supervising five kinds of public health-related products, namely, consumer food, health care products, cosmetics, drugs and medical devices. It is facing big challenges in food and drug safety supervision. Key issues include the problem of completely overhauling and standardizing the fragmented food and drug industry beleaguered with diverse small segments, varied levels of industrialization and focus. In addition, manufacturing of counterfeit drugs and sale of such medicines online to remote areas put more pressure on monitoring. However, SFDA will step up efforts to improve legislation, raise standards and tighten supervision, with special focus on investigating fake drugs posing as medicine, illegitimate additives in patented TCM and illegal drug advertisements. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel